BRIEF published on 11/12/2026 at 07:05, 1 day 21 hours ago DocMorris revoit à la hausse ses prévisions de revenus pour 2026, portées par une forte croissance des médicaments sur ordonnance. Prévisions De Revenus DocMorris Journée Des Marchés Financiers Croissance Sur Ordonnance Expansion De La Télémédecine
BRIEF published on 11/12/2026 at 07:05, 1 day 21 hours ago DocMorris Increases 2026 Revenue Forecast Amid Strong Rx Growth Revenue Forecast Capital Markets Day DocMorris Prescription Growth Telemedicine Expansion
PRESS RELEASE published on 11/12/2026 at 07:00, 1 day 21 hours ago Continued strong Rx growth: DocMorris raises full-year revenue forecast as part of today’s Capital Markets Day
BRIEF published on 11/04/2026 at 07:52, 9 days 20 hours ago TeleClinic Expands into Switzerland, Acquires Medi24 Acquisition Telemedicine DocMorris AG TeleClinic Medi24
BRIEF published on 11/04/2026 at 07:52, 9 days 20 hours ago TeleClinic s'étend en Suisse et acquiert Medi24 Acquisition DocMorris AG Télémédecine TéléClinique Medi24
PRESS RELEASE published on 11/04/2026 at 07:47, 9 days 21 hours ago TeleClinic, a subsidiary of DocMorris, expands into Switzerland: Acquisition of the telemedicine provider Medi24
BRIEF published on 10/15/2026 at 07:05, 29 days 21 hours ago DocMorris Reports Significant Q3 Rx Growth and Achieves EBITDA Breakeven Revenue Increase Digital Services DocMorris EBITDA Breakeven Rx Growth
BRIEF published on 10/15/2026 at 07:05, 29 days 21 hours ago DocMorris annonce une forte croissance de ses ventes de médicaments sur ordonnance au troisième trimestre et atteint le seuil de rentabilité de son EBITDA. Services Numériques Augmentation Des Revenus DocMorris Seuil De Rentabilité De L'EBITDA Croissance Rx
PRESS RELEASE published on 10/15/2026 at 07:00, 29 days 21 hours ago DocMorris accelerates Rx growth to 78% in Q3; EBITDA breakeven already achieved in Q3 and revenue and EBITDA forecast for 2026 raised again DocMorris accelerates Rx growth to 78% in Q3, achieving EBITDA breakeven ahead of schedule. Revenue and EBITDA forecast raised for 2026 Revenue Forecast Digital Healthcare DocMorris EBITDA Breakeven Rx Growth
BRIEF published on 09/11/2026 at 19:49, 2 months 2 days ago DocMorris finalise les paramètres des obligations convertibles Obligations Convertibles Stratégie Financière Emission D'obligations Relations Avec Les Investisseurs DocMorris AG
Published on 11/14/2026 at 01:30, 3 hours 19 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 4 hours 9 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 4 hours 14 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 4 hours 49 minutes ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:15, 5 hours 34 minutes ago Core Critical Metals Corp. Announces $500,000 Non-Brokered Critical Mineral Flow-Through Private Placement
Published on 11/13/2026 at 23:24, 5 hours 24 minutes ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 6 hours 56 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 9 hours 40 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 9 hours 49 minutes ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 17 hours 14 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 17 hours 14 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 20 hours 49 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 1 day 5 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
